approval
saveTRILEPTAL (OXCARBAZEPINE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalOXCARBAZEPINE — FDA approvalMar 2, 2026 · 218d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025 · 378d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 4, 2024 · 762d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 4, 2024 · 762d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalJan 4, 2019 · 2832d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalJan 4, 2019 · 2832d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalMar 22, 2018 · 3120d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalMar 22, 2018 · 3120d ago
same company · ±60 days · 6
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025
- approvalremibrutinib: RHAPSIDO (REMIBRUTINIB) — FDA approvalSep 30, 2025
- approvalcarbamazepine ER: TEGRETOL-XR (CARBAMAZEPINE) — FDA approvalSep 30, 2025
- approvalcarbamazepine ER: TEGRETOL (CARBAMAZEPINE) — FDA approvalSep 30, 2025
- approvalcarbamazepine ER: TEGRETOL (CARBAMAZEPINE) — FDA approvalSep 30, 2025
- approvalasciminib hydrochloride: SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 2, 2025
comments(0)
5-min edit window · permanent after that